Evidence map›Paper›PMID 42257489›Full record

ArticleBlood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis2026

SEER sonorheometry enhances fibrinolysis detection during liver transplantation with heparin.

Todd W Allen, Francesco Viola, Kenichi A Tanaka

Abstract readMulticenter Study
In one paragraph

Article in Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Todd W AllenHemoSonics, LLC, Durham, North Carolina.
Francesco ViolaHemoSonics, LLC, Durham, North Carolina.
Kenichi A TanakaDepartment of Anesthesiology, University of Oklahoma Health, Oklahoma City, Oklahoma, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhole blood viscoelastic tests (VETs) are key for detecting fibrinolysis during orthotopic liver transplantation (OLT). The Quantra System introduces a novel parameter, clot stability to lysis (CSL), for quantifying fibrinolysis. The objective was to assess CSL performance relative to established VET measures.

methodsData were drawn from a multicenter, prospective study of adults undergoing OLT, with Quantra and ROTEM delta testing performed in parallel. This sub-analysis focused on fibrinolysis-positive samples, emphasizing discordant findings between platforms.

resultsAmong 125 enrolled patients, 13 intraoperative samples involving the use of heparin showed discordant results. Calibrated automated thrombinography revealed that Quantra reagents produce slower, reduced thrombin generation compared to ROTEM, diminishing thrombin activatable fibrinolysis inhibitor (TAFI) activity. This enhances sensitivity of Quantra to detect fibrinolysis in these samples.

conclusionsQuantra's CSL parameter demonstrated improved detection of fibrinolysis in heparinized samples and may support individualized fibrinolysis management during OLT. Broader clinical validation is warranted.

Indexed as

FibrinolysisHeparinLiver TransplantationRheologyBlood Coagulation TestsFemaleHumansMaleMiddle AgedProspective StudiesThrombelastographyHeparinclot stability to lysiscoagulation managementfibrinolysisQuantraviscoelastic testing

Identifiers

PMID42257489
PMCPMC13566444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.